NYBC Ventures
Profile and leaders
NYBC Ventures is the corporate venture arm of New York Blood Center Enterprises, a healthcare company. It was founded in 2023 and is based in Boston, United States. It invests from Series B to Series C+. Sectors it names: biotech and life sciences, medical devices.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series B to Series C+ |
| Sectors | Biotech and life sciences, Medical devices |
| Geography | North America |
| Offices | Boston, United States |
Sources: S2 Vitestro: raises USD 70 million Series B, existing investors include NYBC Ventures (2026-03-10); S1 NYBC Ventures: official site (team, board, office, focus).
Where it invests and who leads it
LeadersS1
- Christopher D. Hillyer, MDGeneral Partner and ManagerFind on LinkedInFirm page
- Jay MohrGeneral PartnerFind on LinkedInFirm page
- Meg WoodManaging DirectorFind on LinkedInFirm page
- Kuan YuSenior AnalystFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | New York Blood Center Enterprises | Single source | S1 |
| Parent industry | Healthcare and life sciences | Single source | S1 |
| Founded | 2023 | Single source | S5 |
| Headquarters | Boston, United States | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Stages | Series B, Series C+ (inferred from announced rounds) | Estimate | S2 |
Fund vehicles
| Vehicle | Size | Year | Source |
|---|---|---|---|
| NYBC Ventures inaugural fund (NYBCe commitment) | USD 50M | 2023 | S4 |
Recent rounds
Portfolio
Portfolio companies named in public sources: Vitestro, Star Therapeutics.S2
Official pages
Read the firm's own pages for current information.
- Website nybcventures.org/
Sources
- S1NYBC Ventures: official site (team, board, office, focus)Firm
- S2Vitestro: raises USD 70 million Series B, existing investors include NYBC Ventures (2026-03-10)Portfolio company
- S3Star Therapeutics: raises USD 90 million financing, new investors include NYBC Ventures (2023-09-05)Portfolio company
- S4NYBC Ventures launches USD 50M fund (Business Wire, 2023-05-11)Firm
- S5Fierce Biotech: NYBC Ventures launches with USD 50M for blood and cell therapies (2023-05-11)Press
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by NYBC Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.